BioHarvest Sciences Inc. (BHST) income statement
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.23+0.01 (+0.82%)
Close on Nov 18, 2026Market cap $27.88MP/E –Yield –
BioHarvest Sciences Inc. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 59.3%
- Operating margin
- -16.2%
- Net margin
- -32.3%
- Return on equity, FY2025
- -83.2%
Financial strength
- Current ratio
- 3.97
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 299.6%
Valuation
- P/E ratio
- –
- Price to sales
- 0.81
- Price to book
- 1.10
- Dividend yield
- –
See a number that looks wrong?